Skip to main content
Francine Blei, MD, Pediatric Hematology & Oncology, New York, NY, Lenox Hill Hospital

FrancineBleiMDMBA

Pediatric Hematology & Oncology New York, NY

Co-Director, Vascular Anomalies Program NYU Langone Health/Hassenfeld Children's Hospital

Dr. Blei is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Blei's full profile

Already have an account?

Education & Training

  • Stern School of Business of NYU
    Stern School of Business of NYUMBA, 2008 - 2010
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Hematology/Oncology, 1985 - 1987
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Pediatrics, 1982 - 1985
  • Tel Aviv University Sackler
    Tel Aviv University SacklerClass of 1982
  • Duke University
    Duke UniversityBA

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1982 - 2024
  • ME State Medical License
    ME State Medical License Active through 1991
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2010-2012, 2016-2017, 2019-2021
  • Top Doctors: New York Metro Area Castle Connolly, 2009-2014
  • Fellow (FAAP) American Academy of Pediatrics
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Clinical Practice Guideline for the Management of Infantile Hemangiomas  
    Daniel P Krowchuk, Francine Blei, Peter C Frommelt, Janice L Pelletier, Deborah Sandrock, AAP News

Authored Content

  • Clinical Practice Guideline for the Management of Infantile HemangiomasJanuary 2019

Grant Support

  • Vascular Anomilies, 2005-Research And ControversiesNational Heart, Lung, And Blood Institute2005
  • Vascular Anomalies, 2003 - Research: ControversiesNational Heart, Lung, And Blood Institute2003
  • Vascular Anomalies: Investigations Of Etiologic FactorsNational Heart, Lung, And Blood Institute2000–2003
  • Vascular Anomalies--Investigations Of Etiologic FactorsNational Heart, Lung, And Blood Institute1999
  • Therapy Of Angiomatous Disease With Interferon Alpha-2aNational Center For Research Resources1996–1997
  • Therapy Of Angiomatous Disease With Interferon Alpha-2aNational Center For Research Resources1995–1996

Professional Memberships

Hospital Affiliations